Dompé Farmaceutici S.p.a

This study tested a twice-daily pill called ladarixin in 141 people aged 14-45 recently diagnosed with type 1 diabetes. The goal was to see if the drug could help preserve the body's remaining insulin-producing cells and slow the disease. The trial was stopped early, and results …

This study tested whether adding reparixin to standard care could prevent death or the need for a breathing machine in adults hospitalized with COVID-19 or other pneumonia. About 414 participants were planned, but the trial was stopped early. The goal was to see if reparixin help…

This study aimed to find out how many people with Sjögren's dry eye have reduced feeling in their cornea (the clear front part of the eye). Researchers measured corneal sensitivity and tear production in 103 participants. No treatments were tested; the goal was simply to gather i…